The roles of Jumonji-type oxygenases in human disease

Papers of special note have been highlighted as:

• of interest

References

• 1 Loenarz C, Schofield CJ. Physiological and biochemical aspects of hydroxylations and demethylations catalyzed by human 2-oxoglutarate oxygenases. Trends Biochem. Sci. 36(1), 7–18 (2010).
  MedlineGoogle Scholar
• 2 Takeuchi T, Yamazaki Y, Katoh-Fukui Y et al. Gene trap capture of a novel mouse gene, jumonji, required for neural tube formation. Genes Dev. 9(10), 1211–1222 (1995).▪▪ These papers [2,4,5], collectively establish a eukaryotic family of transcriptional regulators associated with 2-OG and Fe2+-dependent oxygenase activity.
  Medline CASGoogle Scholar
• 3 Takeuchi T, Watanabe Y, Takano-Shimizu T, Kondo S. Roles of jumonji and jumonji family genes in chromatin regulation and development. Dev. Dyn. 235(9), 2449–2459 (2006).
  Medline CASGoogle Scholar
• 4 Balciunas D, Ronne H. Evidence of domain swapping within the jumonji family of transcription factors. Trends Biochem. Sci. 25(6), 274–276 (2000).▪▪ These papers [2,4,5], collectively establish a eukaryotic family of transcriptional regulators associated with 2-OG and Fe2+-dependent oxygenase activity.
  Medline CASGoogle Scholar
• 5 Clissold PM, Ponting CP. Jmj C: cupin metalloenzyme-like domains in jumonji, hairless and phospholipase A2beta. Trends Biochem Sci. 26(1), 7–9 (2001). ▪▪ These papers [2,4,5] collectively establish a eukaryotic family of transcriptional regulators associated with 2-OG and Fe2+-dependent oxygenase activity.
  Medline CASGoogle Scholar
• 6 Ng SS, Kavanagh KL, Mcdonough MA et al. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature 448(7149), 87–91 (2007).
  Medline CASGoogle Scholar
• 7 Shi Y, Lan F, Matson C et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119(7), 941–953 (2004).▪▪ These papers establish two distinct classes of histone demethylases and demonstrate that methylated lysine residues in histones constitute a reversible modification.
  Medline CASGoogle Scholar
• 8 Mcdonough MA, Kavanagh KL, Butler D, Searls T, Oppermann U, Schofield CJ. Structure of human phytanoyl-CoA 2-hydroxylase identifies molecular mechanisms of Refsum disease. J. Biol. Chem. 280(49), 41101–41110 (2005).
  Medline CASGoogle Scholar
• 9 Leung IK, Krojer TJ, Kochan GT et al. Structural and mechanistic studies on gamma-butyrobetaine hydroxylase. Chem. Biol 17(12), 1316–1324 (2010).
  Medline CASGoogle Scholar
• 10 Hautala T, Byers MG, Eddy RL, Shows TB, Kivirikko KI, Myllyla R. Cloning of human lysyl hydroxylase: complete cDNA-derived amino acid sequence and assignment of the gene (PLOD) to chromosome 1p36.3—-p36.2. Genomics 13(1), 62–69 (1992).
  Medline CASGoogle Scholar
• 11 Clifton IJ, Mcdonough MA, Ehrismann D, Kershaw NJ, Granatino N, Schofield CJ. Structural studies on 2-oxoglutarate oxygenases and related double-stranded beta-helix fold proteins. J. Inorganic Biochem. 100(4), 644–669 (2006).
  Medline CASGoogle Scholar
• 12 Klose RJ, Kallin EM, Zhang Y. JmjC-domain-containing proteins and histone demethylation. Nat. Rev. Genet. 7(9), 715–727 (2006).
  Medline CASGoogle Scholar
• 13 Mcdonough MA, Loenarz C, Chowdhury R, Clifton IJ, Schofield CJ. Structural studies on human 2-oxoglutarate dependent oxygenases. Curr. Opin Struct. Biol. 20(6), 659–672 (2010).
  Medline CASGoogle Scholar
• 14 Han Z, Niu T, Chang J et al. Crystal structure of the FTO protein reveals basis for its substrate specificity. Nature 464(7292), 1205–1209 (2010).
  Medline CASGoogle Scholar
• 15 Tsukada Y, Fang J, Erdjument-Bromage H et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature 439(7078), 811–816 (2006).▪▪ These papers establish two distinct classes of histone demethylases and demonstrate that methylated lysine residues in histones constitute a reversible modification.
  Medline CASGoogle Scholar
• 16 Frescas D, Guardavaccaro D, Bassermann F, Koyama-Nasu R, Pagano M. JHDM1B/FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes. Nature 450(7167), 309–313 (2007).
  Medline CASGoogle Scholar
• 17 Lu T, Jackson Mw, Wang B et al. Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65. Proc. Natl Acad. Sci. USA 107(1), 46–51 (2010).
  Medline CASGoogle Scholar
• 18 Yamane K, Toumazou C, Tsukada Y et al. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 125(3), 483–495 (2006).
  Medline CASGoogle Scholar
• 19 Brauchle M, Yao Z, Arora R et al. Protein Complex Interactor Analysis and Differential Activity of KDM3 Subfamily Members Towards H3K9 Methylation. PLoS ONE 8(4), e60549 (2013).
  Medline CASGoogle Scholar
• 20 Hillringhaus L, Yue WW, Rose NR et al. Structural and evolutionary basis for the dual substrate selectivity of human KDM4 histone demethylase family. J. Biol. Chem. 286(48), 41616–41625 (2011).
  Medline CASGoogle Scholar
• 21 Ponnaluri VK, Vavilala DT, Putty S, Gutheil WG, Mukherji M. Identification of non-histone substrates for JMJD2A-C histone demethylases. Biochem. Biophys. Res. Commun. 390(2), 280–284 (2009).
  Medline CASGoogle Scholar
• 22 Trojer P, Zhang J, Yonezawa M et al. Dynamic histone H1 isotype 4 methylation and demethylation by histone lysine methyltransferase G9a/KMT1C and the Jumonji domain-containing JMJD2/KDM4 proteins. J Biol Chem 284(13), 8395–8405 (2009).
  Medline CASGoogle Scholar
• 23 Christensen J, Agger K, Cloos Pa et al. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell 128(6), 1063–1076 (2007).
  Medline CASGoogle Scholar
• 24 Iwase S, Lan F, Bayliss P et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128(6), 1077–1088 (2007).
  Medline CASGoogle Scholar
• 25 Klose RJ, Yan Q, Tothova Z et al. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128(5), 889–900 (2007).
  Medline CASGoogle Scholar
• 26 Lee MG, Norman J, Shilatifard A, Shiekhattar R. Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein. Cell 128(5), 877–887 (2007).
  Medline CASGoogle Scholar
• 27 Seward DJ, Cubberley G, Kim S et al. Demethylation of trimethylated histone H3 Lys4 in vivo by JARID1 JmjC proteins. Nat. Struct. Mol. Biol. 14(3), 240–242 (2007).
  Medline CASGoogle Scholar
• 28 De Santa F, Totaro MG, Prosperini E, Notarbartolo S, Testa G, Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130(6), 1083–1094 (2007).
  MedlineGoogle Scholar
• 29 Hong S, Cho YW, Yu LR, Yu H, Veenstra TD, Ge K. Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc. Natl Acad. Sci. USA 104(47), 18439–18444 (2007).
  Medline CASGoogle Scholar
• 30 Lan F, Bayliss PE, Rinn JL et al. A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 449(7163), 689–694 (2007).
  Medline CASGoogle Scholar
• 31 Lee MG, Villa R, Trojer P et al. Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 318(5849), 447–450 (2007).
  Medline CASGoogle Scholar
• 32 Xiang Y, Zhu Z, Han G, Lin H, Xu L, Chen CD. JMJD3 is a histone H3K27 demethylase. Cell Res. 17(10), 850–857 (2007).
  Medline CASGoogle Scholar
• 33 Wen H, Li J, Song T et al. Recognition of histone H3K4 trimethylation by the plant homeodomain of PHF2 modulates histone demethylation. J. Biol. Chem. 285(13), 9322–9326 (2010).
  Medline CASGoogle Scholar
• 34 Horton JR, Upadhyay AK, Qi HH, Zhang X, Shi Y, Cheng X. Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases. Nat. Struct. Mol. Biol. 17(1), 38–43 (2010).
  Medline CASGoogle Scholar
• 35 Zhu Z, Wang Y, Li X et al. PHF8 is a histone H3K9me2 demethylase regulating rRNA synthesis. Cell Res. 20(7), 794–801 (2010).
  Medline CASGoogle Scholar
• 36 Qi HH, Sarkissian M, Hu GG et al. Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development. Nature 466(7305), 503–507 (2010).
  Medline CASGoogle Scholar
• 37 Tsukada Y, Ishitani T, Nakayama KI. KDM7 is a dual demethylase for histone H3 Lys 9 and Lys 27 and functions in brain development. Genes Dev. 24(5), 432–437 (2010).
  Medline CASGoogle Scholar
• 38 Yue Ww, Hozjan V, Ge W et al. Crystal structure of the PHF8 Jumonji domain, an Nepsilon-methyl lysine demethylase. FEBS Lett. 584(4), 825–830 (2010).
  MedlineGoogle Scholar
• 39 Ge W, Wolf A, Feng T et al. Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humans. Nat. Chem. Biol. 8(12), 960–962 (2012).▪ Demonstrates that Jmj containing enzymes hydroxylate nonchromatin substrates
  Medline CASGoogle Scholar
• 40 Sinha KM, Yasuda H, Coombes MM, Dent SY, De Crombrugghe B. Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase. EMBO J. 29(1), 68–79 (2010).
  Medline CASGoogle Scholar
• 41 Lu Y, Beezhold K, Chang Q et al. Lung cancer-associated JmjC domain protein mdig suppresses formation of tri-methyl lysine 9 of histone H3. Cell Cycle 8(13), 2101–2109 (2009).
  Medline CASGoogle Scholar
• 42 Hsia DA, Tepper CG, Pochampalli MR et al. KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation. Proc. Natl Acad. Sci. USA 107(21), 9671–9676 (2010).
  Medline CASGoogle Scholar
• 43 Youn M-Y, Yokoyama A, Fujiyama-Nakamura S et al. JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation. J. Biol. Chem. 287(16), 12994–13004 (2012).
  Medline CASGoogle Scholar
• 44 Chang B, Chen Y, Zhao Y, Bruick RK. JMJD6 is a histone arginine demethylase. Science 318(5849), 444–447 (2007).
  Medline CASGoogle Scholar
• 45 Webby Cj, Wolf A, Gromak N et al. Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing. Science 325(5936), 90–93 (2009).
  MedlineGoogle Scholar
• 46 Mantri M, Loik ND, Hamed RB, Claridge TDW, Mccullagh JSO, Schofield CJ. The 2-oxoglutarate-dependent oxygenase JMJD6 catalyses oxidation of lysine residues to give 5S-hydroxylysine residues. ChemBioChem 12(4), 531–534 (2011).
  Medline CASGoogle Scholar
• 47 Unoki M, Masuda A, Dohmae N et al. Lysyl 5-hydroxylation, a novel hstone modification, by Jumonji domain containing 6 (JMJD6). J. Biol. Chem. 288(9), 6053–6062 (2013).
  Medline CASGoogle Scholar
• 48 Yang M, Chowdhury R, Ge W et al. Factor-inhibiting hypoxia-inducible factor (FIH) catalyses the post-translational hydroxylation of histidinyl residues within ankyrin repeat domains. FEBS J. 278(7), 1086–1097 (2011).
  Medline CASGoogle Scholar
• 49 Yang M, Ge W, Chowdhury R et al. Asparagine and aspartate hydroxylation of the cytoskeletal ankyrin family is catalyzed by factor-inhibiting hypoxia-inducible factor. J. Biol. Chem. 286(9), 7648–7660 (2011).
  Medline CASGoogle Scholar
• 50 Cockman ME, Lancaster DE, Stolze IP et al. Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl Acad. Sci. USA 103(40), 14767–14772 (2006).
  Medline CASGoogle Scholar
• 51 Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16(12), 1466–1471 (2002).
  Medline CASGoogle Scholar
• 52 Noma A, Ishitani R, Kato M, Nagao A, Nureki O, Suzuki T. Expanding role of the jumonji C domain as an RNA hydroxylase. J. Biol. Chem. 285(45), 34503–34507 (2010).
  Medline CASGoogle Scholar
• 53 Sedgwick B. Repairing DNA-methylation damage. Nat. Rev. Mol. Cell Biol. 5(2), 148–157 (2004).
  Medline CASGoogle Scholar
• 54 Duncan T, Trewick SC, Koivisto P, Bates PA, Lindahl T, Sedgwick B. Reversal of DNA alkylation damage by two human dioxygenases. Proc. Natl Acad. Sci. USA 99(26), 16660–16665 (2002).▪ Establishes the function of human ALKBH enzymes in DNA repair.
  Medline CASGoogle Scholar
• 55 Li Mm, Nilsen A, Shi Y et al. ALKBH4-dependent demethylation of actin regulates actomyosin dynamics. Nat. Commun. 4, 1832 (2013).
  MedlineGoogle Scholar
• 56 Zheng G, Dahl JA, Niu Y et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility. Mol. Cell 49(1), 18–29 (2012).
  MedlineGoogle Scholar
• 57 Fu D, Brophy JA, Chan CT et al. Human AlkB homolog ABH8 Is a tRNA methyltransferase required for wobble uridine modification and DNA damage survival. Mol. Cell Biol. 30(10), 2449–2459 (2010).
  Medline CASGoogle Scholar
• 58 Tahiliani M, Koh KP, Shen Y et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929), 930–935 (2009).▪▪ These papers collectively identify the 5-methylcytosine hydroxylases TET1-3 of critical importance in reversal of DNA methylation.
  Medline CASGoogle Scholar
• 59 Ito S, Shen L, Dai Q et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333(6047), 1300–1303 (2011).▪▪ These papers collectively identify the 5-methylcytosine hydroxylases TET1-3 of critical importance in reversal of DNA methylation.
  Medline CASGoogle Scholar
• 60 Gerken T, Girard CA, Tung YC et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318(5855), 1469–1472 (2007).▪▪ This series of papers establishes the 2-OG oxygenase FTO as risk factor of metabolic diseases and links them to N6-methyladenosine demethylation.
  Medline CASGoogle Scholar
• 61 Jia G, Yang Cg, Yang S et al. Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Lett. 582(23–24), 3313–3319 (2008).
  Medline CASGoogle Scholar
• 62 Landeira D, Sauer S, Poot R et al. Jarid2 is a PRC2 component in embryonic stem cells required for multi-lineage differentiation and recruitment of PRC1 and RNA Polymerase II to developmental regulators. Nat. Cell. Biol. 12(6), 618–624 (2010).▪ These (and other) papers demonstrate an important, nonenzymatic function of Jmj-containing proteins, by providing structural scaffolds in transcriptional complexes.
  Medline CASGoogle Scholar
• 63 Pasini D, Cloos PA, Walfridsson J et al. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 464(7286), 306–310 (2010).▪ These (and other) papers demonstrate an important, nonenzymatic function of Jmj-containing proteins, by providing structural scaffolds in transcriptional complexes.
  Medline CASGoogle Scholar
• 64 Peng JC, Valouev A, Swigut T et al. Jarid2/Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells. Cell 139(7), 1290–1302 (2009).▪ These (and other) papers demonstrate an important, nonenzymatic function of Jmj-containing proteins, by providing structural scaffolds in transcriptional complexes.
  MedlineGoogle Scholar
• 65 Shen X, Kim W, Fujiwara Y et al. Jumonji modulates polycomb activity and self-renewal versus differentiation of stem cells. Cell 139(7), 1303–1314 (2009).▪ These (and other) papers demonstrate an important, nonenzymatic function of Jmj-containing proteins, by providing structural scaffolds in transcriptional complexes
  MedlineGoogle Scholar
• 66 Lewis EB. A gene complex controlling segmentation in Drosophila. Nature 276(5688), 565–570 (1978).
  Medline CASGoogle Scholar
• 67 Struhl G. A gene product required for correct initiation of segmental determination in Drosophila. Nature 293(5827), 36–41 (1981).
  Medline CASGoogle Scholar
• 68 Bracken AP, Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat. Rev. Cancer 9(11), 773–784 (2009).
  Medline CASGoogle Scholar
• 69 Metzger E, Wissmann M, Yin N et al. LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437(7057), 436–439 (2005).
  Medline CASGoogle Scholar
• 70 Allis CD, Berger SL, Cote J et al. New nomenclature for chromatin-modifying enzymes. Cell 131(4), 633–636 (2007).
  Medline CASGoogle Scholar
• 71 Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414), 57–74 (2012).
  MedlineGoogle Scholar
• 72 Ng SS, Yue WW, Oppermann U, Klose RJ. Dynamic protein methylation in chromatin biology. Cell. Mol. Life Sci. 66(3), 407–422 (2009).
  Medline CASGoogle Scholar
• 73 Kooistra SM, Helin K. Molecular mechanisms and potential functions of histone demethylases. Nat. Rev. Mol. Cell Biol. 13(5), 297–311 (2012).
  Medline CASGoogle Scholar
• 74 Pedersen MT, Helin K. Histone demethylases in development and disease. Trends Cell Biol. 20(11), 662–671 (2010).
  Medline CASGoogle Scholar
• 75 Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 150(1), 12–27 (2012).
  Medline CASGoogle Scholar
• 76 Greer El, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13(5), 343–357 (2012).
  MedlineGoogle Scholar
• 77 Mosammaparast N, Shi Y. Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. Annu. Rev. Biochem. 79, 155–179 (2010).
  Medline CASGoogle Scholar
• 78 Ciccone DN, Su H, Hevi S et al. KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints. Nature 461(7262), 415–418 (2009).
  Medline CASGoogle Scholar
• 79 Karytinos A, Forneris F, Profumo A et al. A novel mammalian flavin-dependent histone demethylase. J. Biol. Chem. 284(26), 17775–17782 (2009).
  Medline CASGoogle Scholar
• 80 Wang J, Hevi S, Kurash JK et al. The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat. Genet. 41(1), 125–129 (2009).
  Medline CASGoogle Scholar
• 81 Kerenyi Ma, Shao Z, Hsu YJ et al. Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation. Elife 2, e00633 (2013).
  MedlineGoogle Scholar
• 82 Sprussel A, Schulte JH, Weber S et al. Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation. Leukemia 26(9), 2039–2051 (2012).
  Medline CASGoogle Scholar
• 83 Schenk T, Chen Wc, Gollner S et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat Med 18(4), 605–611 (2012).
  Medline CASGoogle Scholar
• 84 Wang J, Lu F, Ren Q et al. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. Cancer Res 71(23), 7238–7249 (2011).
  Medline CASGoogle Scholar
• 85 Tsai Mc, Manor O, Wan Y et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329(5992), 689–693 (2010).
  MedlineGoogle Scholar
• 86 Wang Y, Zhang H, Chen Y et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 138(4), 660–672 (2009).
  Medline CASGoogle Scholar
• 87 Garcia-Bassets I, Kwon Ys, Telese F et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128(3), 505–518 (2007).
  Medline CASGoogle Scholar
• 88 Huang J, Sengupta R, Espejo AB et al. p53 is regulated by the lysine demethylase LSD1. Nature 449(7158), 105–108 (2007).
  Medline CASGoogle Scholar
• 89 Deaton Am, Bird A. CpG islands and the regulation of transcription. Genes Dev 25(10), 1010–1022 (2011).
  MedlineGoogle Scholar
• 90 Blackledge NP, Zhou JC, Tolstorukov MY, Farcas AM, Park PJ, Klose RJ. CpG islands recruit a histone H3 lysine 36 demethylase. Molecular cell 38(2), 179–190 (2010).
  Medline CASGoogle Scholar
• 91 Farcas Am, Blackledge Np, Sudbery I et al. KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands. Elife 1, e00205 (2012).
  MedlineGoogle Scholar
• 92 He J, Shen L, Wan M, Taranova O, Wu H, Zhang Y. Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes. Nat. Cell Biol. 15(4), 373–384 (2013).
  Medline CASGoogle Scholar
• 93 Wu X, Johansen JV, Helin K. Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation. Mol. Cell 49(6), 1134–1146 (2013).
  Medline CASGoogle Scholar
• 94 Lagarou A, Mohd-Sarip A, Moshkin YM et al. dKDM2 couples histone H2A ubiquitylation to histone H3 demethylation during Polycomb group silencing. Genes Dev. 22(20), 2799–2810 (2008).
  Medline CASGoogle Scholar
• 95 Bartke T, Vermeulen M, Xhemalce B, Robson SC, Mann M, Kouzarides T. Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 143(3), 470–484 (2010).
  Medline CASGoogle Scholar
• 96 Tanaka Y, Okamoto K, Teye K et al. JmjC enzyme KDM2A is a regulator of rRNA transcription in response to starvation. EMBO J. 29(9), 1510–1522 (2010).
  Medline CASGoogle Scholar
• 97 Barrero MJ, Izpisua Belmonte JC. Polycomb complex recruitment in pluripotent stem cells. Nat. Cell Biol. 15(4), 348–350 (2013).
  Medline CASGoogle Scholar
• 98 Du J, Ma Y, Ma P, Wang S, Fan Z. Demethylation of epiregulin gene by histone demethylase FBXL11 and BCL6 corepressor inhibits osteo/dentinogenic differentiation. Stem Cells 31(1), 126–136 (2013).
  Medline CASGoogle Scholar
• 99 Gao R, Dong R, Du J, Ma P, Wang S, Fan Z. Depletion of histone demethylase KDM2A inhibited cell proliferation of stem cells from apical papilla by de-repression of p15(INK4B) and p27 (Kip1.). Mol. Cellular Biochemistry 379(1–2), 115–122 (2013).
  Medline CASGoogle Scholar
• 100 Iuchi S, Green H. Lysine-specific demethylase 2A (KDM2A) normalizes human embryonic stem cell derived keratinocytes. Proc. Natl Acad. Sci. USA 109(24), 9442–9447 (2012).
  Medline CASGoogle Scholar
• 101 Liang G, He J, Zhang Y. Kdm2b promotes induced pluripotent stem cell generation by facilitating gene activation early in reprogramming. Nat. Cell. Biol. 14(5), 457–466 (2012).
  Medline CASGoogle Scholar
• 102 Wang T, Chen K, Zeng X et al. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 9(6), 575–587 (2011).
  Medline CASGoogle Scholar
• 103 Gearhart MD, Corcoran CM, Wamstad JA, Bardwell VJ. Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets. Mol. Cell Biol. 26(18), 6880–6889 (2006).
  Medline CASGoogle Scholar
• 104 He J, Kallin EM, Tsukada Y, Zhang Y. The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b). Nat. Struct. Mol. Biol. 15(11), 1169–1175 (2008).
  Medline CASGoogle Scholar
• 105 Tzatsos A, Pfau R, Kampranis SC, Tsichlis PN. Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus. Proc. Natl Acad. Sci. USA 106(8), 2641–2646 (2009).
  Medline CASGoogle Scholar
• 106 He J, Nguyen At, Zhang Y. KDM2b/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia. Blood 117(14), 3869–3880 (2011).
  Medline CASGoogle Scholar
• 107 Kottakis F, Polytarchou C, Foltopoulou P, Sanidas I, Kampranis SC, Tsichlis PN. FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway. Mol. Cell 43(2), 285–298 (2011).
  Medline CASGoogle Scholar
• 108 Tzatsos A, Paskaleva P, Ferrari F et al. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs. J. Clin. Invest. 123(2), 727–739 (2013).
  Medline CASGoogle Scholar
• 109 Chen H, Giri NC, Zhang R et al. Nickel ions inhibit histone demethylase JMJD1A and DNA repair enzyme ABH2 by replacing the ferrous iron in the catalytic centers. J. Biol. Chem. 285(10), 7374–7383 (2010).
  Medline CASGoogle Scholar
• 110 Hickok JR, Vasudevan D, Antholine WE, Thomas DD. Nitric oxide modifies global histone methylation by Inhibiting Jumonji C domain-containing demethylases. J. Biol. Chem. 288(22), 16004–16015 (2013).
  Medline CASGoogle Scholar
• 111 Yang F, Stenoien DL, Strittmatter EF et al. Phosphoproteome profiling of human skin fibroblast cells in response to low- and high-dose irradiation. J. Proteome Res. 5(5), 1252–1260 (2006).
  Medline CASGoogle Scholar
• 112 Liu Z, Zhou S, Liao L, Chen X, Meistrich M, Xu J. Jmjd1a demethylase-regulated histone modification is essential for cAMP-response element modulator-regulated gene expression and spermatogenesis. J. Biol. Chem. 285(4), 2758–2770 (2010).
  Medline CASGoogle Scholar
• 113 Okada Y, Scott G, Ray MK, Mishina Y, Zhang Y. Histone demethylase JHDM2A is critical for Tnp1 and Prm1 transcription and spermatogenesis. Nature 450(7166), 119–123 (2007).
  Medline CASGoogle Scholar
• 114 Inagaki T, Tachibana M, Magoori K et al. Obesity and metabolic syndrome in histone demethylase JHDM2a-deficient mice. Genes Cells 14(8), 991–1001 (2009).
  Medline CASGoogle Scholar
• 115 Tateishi K, Okada Y, Kallin Em, Zhang Y. Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 458(7239), 757–761 (2009).
  Medline CASGoogle Scholar
• 116 Wellmann S, Bettkober M, Zelmer A et al. Hypoxia upregulates the histone demethylase JMJD1A via HIF-1. Biochem. Biophys. Res. Commun. 372(4), 892–897 (2008).
  Medline CASGoogle Scholar
• 117 Osawa T, Tsuchida R, Muramatsu M et al. Inhibition of histone demethylase JMJD1A improves anti-angiogenic therapy and reduces tumor-associated macrophages. Cancer Res. 73(10), 3019–3028 (2013).
  Medline CASGoogle Scholar
• 118 Yamada D, Kobayashi S, Yamamoto H et al. Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection. Ann. Surg. Oncol. 19( Suppl. 3), S355–364 (2012).
  Google Scholar
• 119 Qi J, Nakayama K, Cardiff Rd et al. Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell 18(1), 23–38 (2010).
  Medline CASGoogle Scholar
• 120 Uemura M, Yamamoto H, Takemasa I et al. Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells. Clin. Cancer Res. 16(18), 4636–4646 (2010).
  Medline CASGoogle Scholar
• 121 Guo X, Shi M, Sun L et al. The expression of histone demethylase JMJD1A in renal cell carcinoma. Neoplasma 58(2), 153–157 (2011).
  Medline CASGoogle Scholar
• 122 Mackinnon RN, Kannourakis G, Wall M, Campbell LJ. A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes. Cancer Genet. 204(4), 187–194 (2011).
  Medline CASGoogle Scholar
• 123 Tang MH, Varadan V, Kamalakaran S, Zhang MG, Dimitrova N, Hicks J. Major chromosomal breakpoint intervals in breast cancer co-localize with differentially methylated regions. Front. Oncol. 2, 197 (2012).
  MedlineGoogle Scholar
• 124 Hu Z, Gomes I, Horrigan SK et al. A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31. Oncogene 20(47), 6946–6954 (2001).
  Medline CASGoogle Scholar
• 125 Kim JY, Kim KB, Eom GH et al. KDM3B is the H3K9 demethylase involved in transcriptional activation of lmo2 in leukemia. Mol. Cell Biol. 32(14), 2917–2933 (2012).
  Medline CASGoogle Scholar
• 126 Lee JW, Choi HS, Gyuris J, Brent R, Moore DD. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol. Endocrinol. 9(2), 243–254 (1995).
  Medline CASGoogle Scholar
• 127 Katoh M. Identification and characterization of TRIP8 gene in silico. Int. J. Mol. Med. 12(5), 817–821 (2003).
  Medline CASGoogle Scholar
• 128 Katoh M. Comparative integromics on JMJD1C gene encoding histone demethylase: conserved POU5F1 binding site elucidating mechanism of JMJD1C expression in undifferentiated ES cells and diffuse-type gastric cancer. Int. J. Oncol. 31(1), 219–223 (2007).
  Medline CASGoogle Scholar
• 129 Wolf SS, Patchev VK, Obendorf M. A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR. Arch. Biochem. Biophys. 460(1), 56–66 (2007).
  Medline CASGoogle Scholar
• 130 Kim SM, Kim JY, Choe NW et al. Regulation of mouse steroidogenesis by WHISTLE and JMJD1C through histone methylation balance. Nucleic Acids Res. 38(19), 6389–6403 (2010).
  Medline CASGoogle Scholar
• 131 Cachon-Gonzalez MB, Fenner S, Coffin JM, Moran C, Best S, Stoye JP. Structure and expression of the hairless gene of mice. Proc. Natl Acad. Sci. USA 91(16), 7717–7721 (1994).
  Medline CASGoogle Scholar
• 132 Thompson CC. Thyroid hormone-responsive genes in developing cerebellum include a novel synaptotagmin and a hairless homolog. J. Neurosci. 16(24), 7832–7840 (1996).
  Medline CASGoogle Scholar
• 133 Hsieh JC, Sisk JM, Jurutka PW et al. Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J. Biol. Chem. 278(40), 38665–38674 (2003).
  Medline CASGoogle Scholar
• 134 Moraitis AN, Giguere V, Thompson CC. Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants. Mol. Cell Biol. 22(19), 6831–6841 (2002).
  Medline CASGoogle Scholar
• 135 Potter GB, Beaudoin GM 3rd, Derenzo CL, Zarach JM, Chen SH, Thompson CC. The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor. Genes Dev. 15(20), 2687–2701 (2001).
  Medline CASGoogle Scholar
• 136 Mi Y, Zhang Y, Shen Yf. Mechanism of JmjC-containing protein Hairless in the regulation of vitamin D receptor function. Biochim. Biophys. Acta 1812(12), 1675–1680 (2011).
  Medline CASGoogle Scholar
• 137 Potter GB, Zarach JM, Sisk JM, Thompson CC. The thyroid hormone-regulated corepressor hairless associates with histone deacetylases in neonatal rat brain. Mol. Endocrinol. 16(11), 2547–2560 (2002).
  Medline CASGoogle Scholar
• 138 Ahmad W, Faiyaz UL, Haque M, Brancolini V et al. Alopecia universalis associated with a mutation in the human hairless gene. Science 279(5351), 720–724 (1998).
  Medline CASGoogle Scholar
• 139 Katoh Y, Katoh M. Comparative integromics on JMJD2A, JMJD2B and JMJD2C: preferential expression of JMJD2C in undifferentiated ES cells. Int. J. Mol. Med. 20(2), 269–273 (2007).
  Medline CASGoogle Scholar
• 140 Berry WL, Janknecht R. KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells. Cancer Res. 73(10), 2936–2942 (2013).
  Medline CASGoogle Scholar
• 141 Crea F, Sun L, Mai A et al. The emerging role of histone lysine demethylases in prostate cancer. Mol. Cancer 11, 52 (2012).
  Medline CASGoogle Scholar
• 142 Cloos PA, Christensen J, Agger K et al. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature 442(7100), 307–311 (2006).
  Medline CASGoogle Scholar
• 143 Shin S, Janknecht R. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem. Biophys. Res. Commun. 359(3), 742–746 (2007).
  Medline CASGoogle Scholar
• 144 Wissmann M, Yin N, Muller Jm et al. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nat. Cell. Biol. 9(3), 347–353 (2007).
  Medline CASGoogle Scholar
• 145 Suikki He, Kujala Pm, Tammela Tl, Van Weerden Wm, Vessella Rl, Visakorpi T. Genetic alterations and changes in expression of histone demethylases in prostate cancer. Prostate 70(8), 889–898 (2010).
  MedlineGoogle Scholar
• 146 Coffey K, Rogerson L, Ryan-Munden C et al. The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover. Nucleic Acids Res. 41(8), 4433–4446 (2013).
  Medline CASGoogle Scholar
• 147 Gaughan L, Stockley J, Coffey K et al. KDM4B is a master regulator of the estrogen receptor signalling cascade. Nucleic Acids Res. 41(14), 6892–6904 (2013).
  Medline CASGoogle Scholar
• 148 Liu G, Bollig-Fischer A, Kreike B et al. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene 28(50), 4491–4500 (2009).
  Medline CASGoogle Scholar
• 149 Li BX, Zhang MC, Luo CL et al. Effects of RNA interference-mediated gene silencing of JMJD2A on human breast cancer cell line MDA-MB-231 in vitro. J. Exp. Clin. Cancer Res. 30, 90 (2011).
  MedlineGoogle Scholar
• 150 Berry WL, Shin S, Lightfoot SA, Janknecht R. Oncogenic features of the JMJD2A histone demethylase in breast cancer. Int. J. Oncol. 41(5), 1701–1706 (2012).
  Medline CASGoogle Scholar
• 151 Yang J, Jubb AM, Pike L et al. The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. Cancer Res. 70(16), 6456–6466 (2010).
  Medline CASGoogle Scholar
• 152 Kawazu M, Saso K, Tong Ki et al. Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS ONE 6(3), e17830 (2011).
  Medline CASGoogle Scholar
• 153 Shi L, Sun L, Li Q et al. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc. Natl Acad. Sci. USA 108(18), 7541–7546 (2011).
  Medline CASGoogle Scholar
• 154 Pollard PJ, Loenarz C, Mole DR et al. Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha. Biochem. J. 416(3), 387–394 (2008).
  Medline CASGoogle Scholar
• 155 Zhu Y, Van Essen D, Saccani S. Cell-type-specific control of enhancer activity by H3K9 trimethylation. Mol. Cell. 46(4), 408–423 (2012).
  Medline CASGoogle Scholar
• 156 Strobl-Mazzulla PH, Sauka-Spengler T, Bronner-Fraser M. Histone demethylase JmjD2A regulates neural crest specification. Dev. Cell 19(3), 460–468
  MedlineGoogle Scholar
• 157 Zhang QJ, Chen HZ, Wang L, Liu DP, Hill JA, Liu ZP. The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J. Clin. Invest. 121(6), 2447–2456 (2011).
  Medline CASGoogle Scholar
• 158 Ye L, Fan Z, Yu B et al. Histone demethylases KDM4B and KDM6B promotes osteogenic differentiation of human MSCs. Cell Stem Cell 11(1), 50–61 (2012).
  Medline CASGoogle Scholar
• 159 Guo L, Li X, Huang JX et al. Histone demethylase Kdm4b functions as a co-factor of C/EBPbeta to promote mitotic clonal expansion during differentiation of 3T3-L1 preadipocytes. Cell Death Differ. 19(12), 1917–1927 (2012).
  Medline CASGoogle Scholar
• 160 Chen Wd, Fu X, Dong B et al. Neonatal activation of the nuclear receptor CAR results in epigenetic memory and permanent change of drug metabolism in mouse liver. Hepatology 56(4), 1499–1509 (2012).
  MedlineGoogle Scholar
• 161 Kim TD, Oh S, Shin S, Janknecht R. Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D. PLoS ONE 7(4), e34618 (2012).
  Medline CASGoogle Scholar
• 162 Wilsker D, Probst L, Wain HM, Maltais L, Tucker PW, Moran E. Nomenclature of the ARID family of DNA-binding proteins. Genomics 86(2), 242–251 (2005).
  Medline CASGoogle Scholar
• 163 Wysocka J, Swigut T, Xiao H et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442(7098), 86–90 (2006).
  Medline CASGoogle Scholar
• 164 Tahiliani M, Mei P, Fang R et al. The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 447(7144), 601–605 (2007).
  Medline CASGoogle Scholar
• 165 Defeo-Jones D, Huang PS, Jones RE et al. Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product. Nature 352(6332), 251–254 (1991).
  Medline CASGoogle Scholar
• 166 Benevolenskaya EV, Murray HL, Branton P, Young RA, Kaelin WG Jr. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol. Cell 18(6), 623–635 (2005).
  Medline CASGoogle Scholar
• 167 Chicas A, Kapoor A, Wang X et al. H3K4 demethylation by Jarid1a and Jarid1b contributes to retinoblastoma-mediated gene silencing during cellular senescence. Proc. Natl Acad. Sci. USA 109(23), 8971–8976 (2012).
  Medline CASGoogle Scholar
• 168 Ditacchio L, Le HD, Vollmers C et al. Histone lysine demethylase JARID1a activates CLOCK-BMAL1 and influences the circadian clock. Science 333(6051), 1881–1885 (2011).
  Medline CASGoogle Scholar
• 169 De Rooij JD, Hollink IH, Arentsen-Peters ST et al. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia27(12), 2280–2288 (2013).
  MedlineGoogle Scholar
• 170 Pointon JJ, Harvey D, Karaderi T, Appleton LH, Farrar C, Wordsworth BP. The histone demethylase JARID1A is associated with susceptibility to ankylosing spondylitis. Genes Immun. 12(5), 395–398 (2011).
  Medline CASGoogle Scholar
• 171 Sharma SV, Lee DY, Li B et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141(1), 69–80 (2010).
  Medline CASGoogle Scholar
• 172 Cellot S, Hope KJ, Chagraoui J et al. RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity. Blood 122(9), 1545–1555 (2013).
  Medline CASGoogle Scholar
• 173 Dey BK, Stalker L, Schnerch A, Bhatia M, Taylor-Papidimitriou J, Wynder C. The histone demethylase KDM5b/JARID1b plays a role in cell fate decisions by blocking terminal differentiation. Mol. Cell Biol 28(17), 5312–5327 (2008).
  Medline CASGoogle Scholar
• 174 Schmitz Su, Albert M, Malatesta M et al. Jarid1b targets genes regulating development and is involved in neural differentiation. EMBO J. 30(22), 4586–4600 (2011).
  MedlineGoogle Scholar
• 175 Li Q, Shi L, Gui B et al. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14. Cancer Res. 71(21), 6899–6908 (2011).
  Medline CASGoogle Scholar
• 176 Kuzbicki L, Lange D, Straczynska-Niemiec A, Chwirot BW. JARID1B expression in human melanoma and benign melanocytic skin lesions. Melanoma Res. 23(1), 8–12 (2013).
  Medline CASGoogle Scholar
• 177 Lu Pj, Sundquist K, Baeckstrom D et al. A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J. Biol. Chem. 274(22), 15633–15645 (1999).
  MedlineGoogle Scholar
• 178 Roesch A, Fukunaga-Kalabis M, Schmidt EC et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141(4), 583–594 (2010).
  Medline CASGoogle Scholar
• 179 Wouters J, Stas M, Gremeaux L et al. The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis. PLoS ONE 8(10), e76550 (2013).
  Medline CASGoogle Scholar
• 180 Jensen LR, Amende M, Gurok U et al. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. Am. J. Hum. Genet. 76(2), 227–236 (2005).
  Medline CASGoogle Scholar
• 181 Agulnik Ai, Mitchell Mj, Mattei Mg et al. A novel X gene with a widely transcribed Y-linked homologue escapes X-inactivation in mouse and human. Hum. Mol. Genet. 3(6), 879–884 (1994).
  MedlineGoogle Scholar
• 182 Adegbola A, Gao H, Sommer S, Browning M. A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD). Am. J. Med. Genet. Part A 146A(4), 505–511 (2008).
  Medline CASGoogle Scholar
• 183 Niu X, Zhang T, Liao L et al. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C. Oncogene 31(6), 776–786 (2012).
  Medline CASGoogle Scholar
• 184 Agulnik Ai, Mitchell Mj, Lerner Jl, Woods Dr, Bishop Ce. A mouse Y chromosome gene encoded by a region essential for spermatogenesis and expression of male-specific minor histocompatibility antigens. Hum. Mol. Genet. 3(6), 873–878 (1994).
  MedlineGoogle Scholar
• 185 Scott DM, Ehrmann IE, Ellis PS et al. Identification of a mouse male-specific transplantation antigen, H-Y. Nature 376(6542), 695–698 (1995).
  Medline CASGoogle Scholar
• 186 Wang W, Meadows LR, Den Haan JM et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 269(5230), 1588–1590 (1995).
  Medline CASGoogle Scholar
• 187 Akimoto C, Kitagawa H, Matsumoto T, Kato S. Spermatogenesis-specific association of SMCY and MSH5. Genes Cells 13(6), 623–633 (2008).
  Medline CASGoogle Scholar
• 188 Perinchery G, Sasaki M, Angan A, Kumar V, Carroll P, Dahiya R. Deletion of Y-chromosome specific genes in human prostate cancer. J. Urol. 163(4), 1339–1342 (2000).
  Medline CASGoogle Scholar
• 189 Kruidenier L, Chung CW, Cheng Z et al. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488(7411), 404–408 (2012).
  Medline CASGoogle Scholar
• 190 Sola S, Xavier JM, Santos DM et al. p53 interaction with JMJD3 results in its nuclear distribution during mouse neural stem cell differentiation. PLoS ONE 6(3), e18421 (2011).
  Medline CASGoogle Scholar
• 191 Miller SA, Mohn SE, Weinmann AS. Jmjd3 and UTX play a demethylase-independent role in chromatin remodeling to regulate T-box family member-dependent gene expression. Mol. Cell 40(4), 594–605 (2010).
  Medline CASGoogle Scholar
• 192 Miller SA, Weinmann AS. Molecular mechanisms by which T-bet regulates T-helper cell commitment. Immunol. Rev. 238(1), 233–246 (2010).
  Medline CASGoogle Scholar
• 193 Bernstein BE, Mikkelsen TS, Xie X et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2), 315–326 (2006).
  Medline CASGoogle Scholar
• 194 Awe JP, Byrne JA. Identifying candidate oocyte reprogramming factors using cross-species global transcriptional analysis. Cell Reprogram. 15(2), 126–133 (2013).
  Medline CASGoogle Scholar
• 195 Canovas S, Cibelli JB, Ross PJ. Jumonji domain-containing protein 3 regulates histone 3 lysine 27 methylation during bovine preimplantation development. Proc. Natl Acad. Sci. USA 109(7), 2400–2405 (2012).
  Medline CASGoogle Scholar
• 196 Jiang W, Wang J, Zhang Y. Histone H3K27me3 demethylases KDM6A and KDM6B modulate definitive endoderm differentiation from human ESCs by regulating WNT signaling pathway. Cell Res. 23(1), 122–130 (2013).
  Medline CASGoogle Scholar
• 197 Kim SW, Yoon SJ, Chuong E et al. Chromatin and transcriptional signatures for Nodal signaling during endoderm formation in hESCs. Dev. Biol. 357(2), 492–504 (2011).
  Medline CASGoogle Scholar
• 198 Agger K, Cloos PA, Christensen J et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449(7163), 731–734 (2007).
  Medline CASGoogle Scholar
• 199 Shahhoseini M, Taghizadeh Z, Hatami M, Baharvand H. Retinoic acid dependent histone 3 demethylation of the clustered HOX genes during neural differentiation of human embryonic stem cells. Biochem. Cell Biol. 91(2), 116–122 (2013).
  Medline CASGoogle Scholar
• 200 Zhao W, Li Q, Ayers S et al. Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination. Cell 152(5), 1037–1050 (2013).
  Medline CASGoogle Scholar
• 201 Yasui T, Hirose J, Tsutsumi S, Nakamura K, Aburatani H, Tanaka S. Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1. J. Bone Miner. Res. 26(11), 2665–2671 (2011).
  Medline CASGoogle Scholar
• 202 Burgold T, Voituron N, Caganova M et al. The H3K27 demethylase JMJD3 is required for maintenance of the embryonic respiratory neuronal network, neonatal breathing, and survival. Cell Rep. 2(5), 1244–1258 (2012).
  Medline CASGoogle Scholar
• 203 Jepsen K, Solum D, Zhou T et al. SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature 450(7168), 415–419 (2007).
  Medline CASGoogle Scholar
• 204 Estaras C, Akizu N, Garcia A, Beltran S, De La Cruz X, Martinez-Balbas MA. Genome-wide analysis reveals that Smad3 and JMJD3 HDM co-activate the neural developmental program. Development 139(15), 2681–2691 (2012).
  Medline CASGoogle Scholar
• 205 Fei T, Xia K, Li Z et al. Genome-wide mapping of SMAD target genes reveals the role of BMP signaling in embryonic stem cell fate determination. Genome Res. 20(1), 36–44 (2010).
  Medline CASGoogle Scholar
• 206 Dai JP, Lu JY, Zhang Y, Shen YF. Jmjd3 activates Mash1 gene in RA-induced neuronal differentiation of P19 cells. J. Cell Biochem. 110(6), 1457–1463 (2010).
  Medline CASGoogle Scholar
• 207 Giovarelli M, Bucci G, Pasero M, Gherzi R, Briata P. KSRP silencing favors neural differentiation of P19 teratocarcinoma cells. Biochim. Biophys. Acta 1829(5), 469–479 (2013).
  Google Scholar
• 208 Lederer D, Grisart B, Digilio MC et al. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am. J. Human Genet. 90(1), 119–124 (2011).
  MedlineGoogle Scholar
• 209 Priolo M, Micale L, Augello B et al. Absence of deletion and duplication of MLL2 and KDM6A genes in a large cohort of patients with Kabuki syndrome. Mol. Genet. Metab. 107(3), 627–629 (2012).
  Medline CASGoogle Scholar
• 210 Das ND, Jung KH, Choi MR, Yoon HS, Kim SH, Chai YG. Gene networking and inflammatory pathway analysis in a JMJD3 knockdown human monocytic cell line. Cell Biochem. Funct. 30(3), 224–232 (2012).
  Medline CASGoogle Scholar
• 211 Wei Y, Chen R, Dimicoli S et al. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. Leukemia 27(11), 2177–2186 (2013).
  Medline CASGoogle Scholar
• 212 De Santa F, Narang V, Yap ZH et al. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J. 28(21), 3341–3352 (2009).
  MedlineGoogle Scholar
• 213 Ishii M, Wen H, Corsa CA et al. Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 114(15), 3244–3254 (2009).
  Medline CASGoogle Scholar
• 214 Satoh T, Takeuchi O, Vandenbon A et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat. Immunol. 11(10), 936–944 (2010).
  Medline CASGoogle Scholar
• 215 Zhang Q, Long H, Liao J et al. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus. J. Autoimmun. 37(3), 180–189 (2011).
  Medline CASGoogle Scholar
• 216 Sen Gl, Webster DE, Barragan DI, Chang HY, Khavari PA. Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Genes Dev. 22(14), 1865–1870 (2008).
  MedlineGoogle Scholar
• 217 Shaw T, Martin P. Epigenetic reprogramming during wound healing. loss of polycomb-mediated silencing may enable upregulation of repair genes. EMBO Rep. 10(8), 881–886 (2009).
  Medline CASGoogle Scholar
• 218 Ciavatta DJ, Yang J, Preston GA et al. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J. Clin. Invest. 120(9), 3209–3219 (2010).
  Medline CASGoogle Scholar
• 219 Dumon S, Walton DS, Volpe G et al. Itga2b regulation at the onset of definitive hematopoiesis and commitment to differentiation. PLoS ONE 7(8), e43300 (2012).
  Medline CASGoogle Scholar
• 220 Anderton JA, Bose S, Vockerodt M et al. The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma. Oncogene 30(17), 2037–2043 (2011).
  Medline CASGoogle Scholar
• 221 Mclaughlin-Drubin ME, Crum CP, Munger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc. Natl Acad. Sci. USA 108(5), 2130–2135 (2011).
  Medline CASGoogle Scholar
• 222 Shen Y, Guo X, Wang Y et al. Expression and significance of histone H3K27 demethylases in renal cell carcinoma. BMC Cancer 12, 470 (2012).
  Medline CASGoogle Scholar
• 223 Svotelis A, Bianco S, Madore J et al. H3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERalpha ligand dependency. EMBO J. 30(19), 3947–3961 (2011).
  Medline CASGoogle Scholar
• 224 Bunt J, Hasselt NA, Zwijnenburg DA, Koster J, Versteeg R, Kool M. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels. Acta Neuropathol. 125(3), 385–394 (2012).
  MedlineGoogle Scholar
• 225 Dubuc Am, Remke M, Korshunov A et al. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Acta Neuropathol. 125(3), 373–384 (2012).
  MedlineGoogle Scholar
• 226 Agger K, Cloos PA, Rudkjaer L et al. The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev. 23(10), 1171–1176 (2009).
  Medline CASGoogle Scholar
• 227 Agherbi H, Gaussmann-Wenger A, Verthuy C, Chasson L, Serrano M, Djabali M. Polycomb mediated epigenetic silencing and replication timing at the INK4a/ARF locus during senescence. PLoS ONE 4(5), e5622 (2009).
  MedlineGoogle Scholar
• 228 Barradas M, Anderton E, Acosta JC et al. Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev. 23(10), 1177–1182 (2009).
  Medline CASGoogle Scholar
• 229 Ramadoss S, Chen X, Wang Cy. Histone demethylase KDM6B promotes epithelial-mesenchymal transition. J. Biol. Chem. 287(53), 44508–44517 (2012).
  Medline CASGoogle Scholar
• 230 Pereira F, Barbachano A, Silva J et al. KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum. Mol. Genet. 20(23), 4655–4665 (2011).
  Medline CASGoogle Scholar
• 231 Pereira F, Barbachano A, Singh PK, Campbell MJ, Munoz A, Larriba MJ. Vitamin D has wide regulatory effects on histone demethylase genes. Cell Cycle 11(6), 1081–1089 (2012).
  Medline CASGoogle Scholar
• 232 Chen C, Bartenhagen C, Gombert M et al. Next-generation-sequencing-based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia. Genes Chromosomes Cancer 52(6), 564–579 (2013).
  Medline CASGoogle Scholar
• 233 Van Haaften G, Dalgliesh GL, Davies H et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat. Genet. 41(5), 521–523 (2009).
  Medline CASGoogle Scholar
• 234 Laaser I, Theis FJ, De Angelis MH, Kolb HJ, Adamski J. Huge splicing frequency in human Y chromosomal UTY gene. OMICS 15(3), 141–154 (2011).
  Medline CASGoogle Scholar
• 235 Warren EH, Gavin MA, Simpson E et al. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J. Immunol. 164(5), 2807–2814 (2000).
  Medline CASGoogle Scholar
• 236 Bloomer LD, Nelson CP, Eales J et al. Male-specific region of the Y chromosome and cardiovascular risk: phylogenetic analysis and gene expression studies. Arterioscler. Thromb. Vasc. Biol. 33(7), 1722–1727 (2013).
  Medline CASGoogle Scholar
• 237 Fortschegger K, Shiekhattar R. Plant homeodomain fingers form a helping hand for transcription. Epigenetics 6(1), 4–8 (2010).
  Google Scholar
• 238 Dai J, Sultan S, Taylor SS, Higgins JM. The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment. Genes Dev. 19(4), 472–488 (2005).
  Medline CASGoogle Scholar
• 239 Fortschegger K, De Graaf P, Outchkourov Ns, Van Schaik FM, Timmers HT, Shiekhattar R. PHF8 targets histone methylation and RNA polymerase II to activate transcription. Mol. Cell Biol. 30(13), 3286–3298 (2010).
  Medline CASGoogle Scholar
• 240 Liu W, Tanasa B, Tyurina OV et al. PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression. Nature 466(7305), 508–512 (2010).
  Medline CASGoogle Scholar
• 241 Kleine-Kohlbrecher D, Christensen J, Vandamme J et al. A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation. Mol. Cell 38(2), 165–178 (2010).
  Medline CASGoogle Scholar
• 242 Feng W, Yonezawa M, Ye J, Jenuwein T, Grummt I. PHF8 activates transcription of rRNA genes through H3K4me3 binding and H3K9me1/2 demethylation. Nat. Struct. Mol. Biol. 17(4), 445–450 (2010).
  Medline CASGoogle Scholar
• 243 Arteaga MF, Mikesch JH, Qiu J et al. The histone demethylase PHF8 governs retinoic acid response in acute promyelocytic leukemia. Cancer Cell 23(3), 376–389 (2013).
  Medline CASGoogle Scholar
• 244 Stender Jd, Pascual G, Liu W et al. Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. Mol. Cell 48(1), 28–38 (2012).
  MedlineGoogle Scholar
• 245 Huang C, Xiang Y, Wang Y et al. Dual-specificity histone demethylase KIAA1718 (KDM7A) regulates neural differentiation through FGF4. Cell Res. 20(2), 154–165 (2010).
  Medline CASGoogle Scholar
• 246 Sinha S, Singh RK, Alam N, Roy A, Roychoudhury S, Panda CK. Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region. pathological significance in early- and late-onset breast carcinoma. Mol. Cancer 7, 84 (2008).
  MedlineGoogle Scholar
• 247 Abidi F, Miano M, Murray J, Schwartz C. A novel mutation in the PHF8 gene is associated with X-linked mental retardation with cleft lip/cleft palate. Clin. Genet. 72(1), 19–22 (2007).
  Medline CASGoogle Scholar
• 248 Koivisto AM, Ala-Mello S, Lemmela S, Komu HA, Rautio J, Jarvela I. Screening of mutations in the PHF8 gene and identification of a novel mutation in a Finnish family with XLMR and cleft lip/cleft palate. Clin. Genet. 72(2), 145–149 (2007).
  Medline CASGoogle Scholar
• 249 Laumonnier F, Holbert S, Ronce N et al. Mutations in PHF8 are associated with X linked mental retardation and cleft lip/cleft palate. J. Med. Genet. 42(10), 780–786 (2005).
  Medline CASGoogle Scholar
• 250 Siderius LE, Hamel BC, Van Bokhoven H et al. X-linked mental retardation associated with cleft lip/palate maps to Xp11.3-q21.3. Am. J. Med. Genet. 85(3), 216–220 (1999).
  Medline CASGoogle Scholar
• 251 Qiao Y, Liu X, Harvard C et al. Autism-associated familial microdeletion of Xp11.22. Clin. Genet. 74(2), 134–144 (2008).
  Medline CASGoogle Scholar
• 252 Nava C, Lamari F, Heron D et al. Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Transl Psychiatry 2, e179 (2012).
  Medline CASGoogle Scholar
• 253 Aragones J, Fraisl P, Baes M, Carmeliet P. Oxygen sensors at the crossroad of metabolism. Cell Metab. 9(1), 11–22 (2009).
  Medline CASGoogle Scholar
• 254 Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5(5), 343–354 (2004).
  Medline CASGoogle Scholar
• 255 Melvin A, Mudie S, Rocha S. The chromatin remodeler ISWI regulates the cellular response to hypoxia: role of FIH. Mol. Biol.  22(21), 4171–4181 (2011).
  CASGoogle Scholar
• 256 Zhang N, Fu Z, Linke S et al. The asparaginyl hydroxylase factor inhibiting HIF-1α is an essential regulator of metabolism. Cell Metabolism 11(5), 364–378 (2010).
  Medline CASGoogle Scholar
• 257 Liu C-J, Tsai M-M, Hung P-S et al. miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Research 70(4), 1635–1644 (2010).
  Medline CASGoogle Scholar
• 258 Kroeze SGC, Vermaat JS, Van Brussel A et al. Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients. Eur. J. Cancer 46(18), 3375–3382 (2010).
  Medline CASGoogle Scholar
• 259 Khan MN, Bhattacharyya T, Andrikopoulos P et al. Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1[alpha]-mediated apoptosis. Br. J. Cancer 104(7), 1151–1159 (2011).
  Medline CASGoogle Scholar
• 260 Andersen S, Donnem T, Stenvold H et al. Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survival. PLoS ONE 6(8), e23847 (2011).
  Medline CASGoogle Scholar
• 261 Hyseni A, Groep P, Wall E, Diest P. Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression. Cell Oncol. 34(6), 565–570 (2011).
  CASGoogle Scholar
• 262 Liu Y, Higashitsuji H, Higashitsuji H et al. Overexpression of gankyrin in mouse hepatocytes induces hemangioma by suppressing factor inhibiting hypoxia-inducible factor-1 (FIH-1) and activating hypoxia-inducible factor-1. Biochem. Biophys. Res. Comm. 432(1), 22–27 (2013).
  Medline CASGoogle Scholar
• 263 Tsuneoka M, Koda Y, Soejima M, Teye K, Kimura H. A novel myc target gene, mina53, that is involved in cell proliferation. J. Biol. Chem. 277(38), 35450–35459 (2002).
  Medline CASGoogle Scholar
• 264 Hoffman B, Liebermann DA. Apoptotic signaling by c-MYC. Oncogene 27(50), 6462–6472 (2008).
  Medline CASGoogle Scholar
• 265 Lu Y, Chang Q, Zhang Y et al. Lung cancer-associated JmjC domain protein mdig suppresses formation of tri-methyl lysine 9 of histone H3. Cell Cycle 8(13), 2101–2109 (2009).
  Medline CASGoogle Scholar
• 266 Fukahori S, Yano H, Tsuneoka M et al. Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma. J. Pediatric Surg. 42(11), 1831–1840 (2007).
  MedlineGoogle Scholar
• 267 Ishizaki H, Yano H, Tsuneoka M et al. Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma. Pathol. Int. 57(10), 672–680 (2007).
  Medline CASGoogle Scholar
• 268 Komiya K, Sueoka-Aragane N, Sato A et al. Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer. Lung Cancer 69(2), 232–238 (2010).
  MedlineGoogle Scholar
• 269 Tan XP, Zhang Q, Dong WG, Lei XW, Yang ZR. Upregulated expression of Mina53 in cholangiocarcinoma and its clinical significance. Oncol. Lett. 3(5), 1037–1041 (2012).
  MedlineGoogle Scholar
• 270 Teye K, Tsuneoka M, Arima N et al. Increased expression of a Myc target gene Mina53 in human colon cancer. Am. J. Pathol. 164(1), 205–216 (2004).
  Medline CASGoogle Scholar
• 271 Tsuneoka M, Fujita H, Arima N et al. Mina53 as a Potential Prognostic Factor for Esophageal Squamous Cell Carcinoma. Clin. Cancer Res. 10(21), 7347–7356 (2004).
  Medline CASGoogle Scholar
• 272 Tsuneoka M, Nishimune Y, Ohta K et al. Expression of Mina53, a product of a Myc target gene in mouse testis. Int. J. Androl. 29(2), 323–330 (2006).
  Medline CASGoogle Scholar
• 273 Zhang Y, Lu Y, Yuan BZ et al. The Human mineral dust-induced gene, mdig, is a cell growth regulating gene associated with lung cancer. Oncogene 24(31), 4873–4882 (2005).
  Medline CASGoogle Scholar
• 274 Mori T, Okamoto K, Tanaka Y et al. Ablation of mina53 in mice reduces allergic response in the airways. Cell Struct. Funct. 38(2), 155–167 (2013).
  Medline CASGoogle Scholar
• 275 Yosef N, Shalek Ak, Gaublomme JT et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature 496(7446), 461–468 (2013).
  Medline CASGoogle Scholar
• 276 Eilbracht J, Reichenzeller M, Hergt M et al. NO66, a highly conserved dual location protein in the nucleolus and in a special type of synchronously replicating chromatin. Mol Biol Cell 15(4), 1816–1832 (2004).
  Medline CASGoogle Scholar
• 277 Brien GL, Gambero G, O’Connell DJ et al. Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation. Nat. Struct. Mol. Biol. 19(12), 1273–1281 (2012).
  Medline CASGoogle Scholar
• 278 Tao Y, Wu M, Zhou X et al. Structural Insights into histone demethylase NO66 in interaction with osteoblast-specific transcription factor Osterix and gene repression. J. Biol. Chem. 288(23), 16430–16437 (2013).
  Medline CASGoogle Scholar
• 279 Suzuki C, Takahashi K, Hayama S et al. Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer. Mol. Cancer Ther. 6(2), 542–551 (2007).
  Medline CASGoogle Scholar
• 280 Jones MA, Covington MF, Ditacchio L, Vollmers C, Panda S, Harmer Sl. Jumonji domain protein JMJD5 functions in both the plant and human circadian systems. Proc. Natl Acad. Sci. USA 107(50), 21623–21628 (2010).
  Medline CASGoogle Scholar
• 281 Oh S, Janknecht R. Histone demethylase JMJD5 is essential for embryonic development. Biochem. Biophys. Res. Comm. 420(1), 61–65 (2012).
  Medline CASGoogle Scholar
• 282 Ishimura A, Minehata K-I, Terashima M, Kondoh G, Hara T, Suzuki T. Jmjd5, an H3K36me2 histone demethylase, modulates embryonic cell proliferation through the regulation of Cdkn1a expression. Development 139(4), 749–759 (2012).
  Medline CASGoogle Scholar
• 283 Cikala M, Alexandrova O, David CN et al. The phosphatidylserine receptor from Hydra is a nuclear protein with potential Fe(II) dependent oxygenase activity. BMC Cell Biol. 5, 26 (2004).
  MedlineGoogle Scholar
• 284 Mantri M, Krojer T, Bagg EA et al. Crystal structure of the 2-oxoglutarate- and Fe(II)-dependent lysyl hydroxylase JMJD6. J. Mol. Biol. 401(2), 211–222 (2010).
  Medline CASGoogle Scholar
• 285 Hong X, Zang J, White J et al. Interaction of JMJD6 with single-stranded RNA. Proc. Natl Acad. Sci. USA 107(33), 14568–14572 (2010).
  Medline CASGoogle Scholar
• 286 Bose J, Gruber AD, Helming L et al. The phosphatidylserine receptor has essential functions during embryogenesis but not in apoptotic cell removal. J. Biol. 3(4), 15 (2004).
  MedlineGoogle Scholar
• 287 Kunisaki Y, Masuko S, Noda M et al. Defective fetal liver erythropoiesis and T lymphopoiesis in mice lacking the phosphatidylserine receptor. Blood 103(9), 3362–3364 (2004).
  Medline CASGoogle Scholar
• 288 Schneider JE, Bose J, Bamforth SD et al. Identification of cardiac malformations in mice lacking Ptdsr using a novel high-throughput magnetic resonance imaging technique. BMC Dev. Biol. 4, 16 (2004).
  MedlineGoogle Scholar
• 289 Hahn P, Wegener I, Burrells A et al. Analysis of Jmjd6 cellular localization and testing for its involvement in histone demethylation. PLoS ONE 5(10), e13769 (2010).
  MedlineGoogle Scholar
• 290 Lee Y, Miller L, Chan X et al. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer. Breast Cancer Res. 14(3), R85 (2012).
  Medline CASGoogle Scholar
• 291 Ghosh M, Loper R, Gelb Mh, Leslie Cc. Identification of the expressed form of human cytosolic phospholipase A2beta (cPLA2beta): cPLA2beta3 is a novel variant localized to mitochondria and early endosomes. J Biol Chem 281(24), 16615–16624 (2006).
  Medline CASGoogle Scholar
• 292 Ding X, Pan H, Li J et al. Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis. Sci. Signal. 6(273), ra28 21–13, S20–S15 (2013).
  Google Scholar
• 293 Liu C, Gilmont Rr, Benndorf R, Welsh MJ. Identification and characterization of a novel protein from Sertoli cells, PASS1, that associates with mammalian small stress protein hsp27. J. Biol. Chem. 275(25), 18724–18731 (2000).
  Medline CASGoogle Scholar
• 294 Jiang M, Ma Y, Cheng H et al. Molecular cloning and characterization of a novel human gene (HSPBAP1) from human fetal brain. Cytogenet. Cell Genet. 95(1–2), 48–51 (2001).
  Medline CASGoogle Scholar
• 295 Srivastava AK, Renusch SR, Naiman NE et al. Mutant HSPB1 overexpression in neurons is sufficient to cause age-related motor neuronopathy in mice. Neurobiol. Dis. 47(2), 163–173 (2012).
  Medline CASGoogle Scholar
• 296 Xi ZQ, Sun JJ, Wang XF et al. HSPBAP1 is found extensively in the anterior temporal neocortex of patients with intractable epilepsy. Synapse 61(9), 741–747 (2007).
  Medline CASGoogle Scholar
• 297 Xi ZQ, Xiao F, Yuan J et al. Gene expression analysis on anterior temporal neocortex of patients with intractable epilepsy. Synapse 63(11), 1017–1028 (2009).
  Medline CASGoogle Scholar
• 298 Aas PA, Otterlei M, Falnes PO et al. Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA. Nature 421(6925), 859–863 (2003).▪ Establishes the function of human ALKBH enzymes in DNA repair.
  Medline CASGoogle Scholar
• 299 Dango S, Mosammaparast N, Sowa ME et al. DNA unwinding by ASCC3 helicase is coupled to ALKBH3-dependent DNA alkylation repair and cancer cell proliferation. Mol. Cell 44(3), 373–384 (2011).
  Medline CASGoogle Scholar
• 300 Fu D, Samson LD. Direct repair of 3,N(4)-ethenocytosine by the human ALKBH2 dioxygenase is blocked by the AAG/MPG glycosylase. DNA Repair (Amst.) 11(1), 46–52 (2012).
  Medline CASGoogle Scholar
• 301 Lee DH, Jin SG, Cai S, Chen Y, Pfeifer GP, O’connor TR. Repair of methylation damage in DNA and RNA by mammalian AlkB homologues. J. Biol. Chem. 280(47), 39448–39459 (2005).
  Medline CASGoogle Scholar
• 302 Muller TA, Meek K, Hausinger RP. Human AlkB homologue 1 (ABH1) exhibits DNA lyase activity at abasic sites. DNA Repair (Amst.) 9(1), 58–65 (2010).
  MedlineGoogle Scholar
• 303 Westbye MP, Feyzi E, Aas PA et al. Human AlkB homolog 1 is a mitochondrial protein that demethylates 3-methylcytosine in DNA and RNA. J. Biol. Chem. 283(36), 25046–25056 (2008).
  Medline CASGoogle Scholar
• 304 Bethke L, Murray A, Webb E et al. Comprehensive analysis of DNA repair gene variants and risk of meningioma. J. Natl Cancer Inst. 100(4), 270–276 (2008).
  Medline CASGoogle Scholar
• 305 Fujii T, Shimada K, Anai S, Fujimoto K, Konishi N. ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression. Cancer Sci. 104(3), 321–327 (2013).
  Medline CASGoogle Scholar
• 306 Hu L, Wu C, Zhao X et al. Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy. Clin. Cancer Res. 18(19), 5507–5514 (2012).
  Medline CASGoogle Scholar
• 307 Johannessen TC, Prestegarden L, Grudic A, Hegi ME, Tysnes BB, Bjerkvig R. The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells. Neuro Oncol. 15(3), 269–278 (2013).
  Medline CASGoogle Scholar
• 308 Koike K, Ueda Y, Hase H et al. anti-tumor effect of AlkB homolog 3 knockdown in hormone- independent prostate cancer cells. Curr. Cancer Drug Targets 12(7), 847–856 (2012).
  Medline CASGoogle Scholar
• 309 Shimada K, Fujii T, Tsujikawa K, Anai S, Fujimoto K, Konishi N. ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals. Clin. Cancer Res. 18(19), 5247–5255 (2012).
  Medline CASGoogle Scholar
• 310 Tasaki M, Shimada K, Kimura H, Tsujikawa K, Konishi N. ALKBH3, a human AlkB homologue, contributes to cell survival in human non-small-cell lung cancer. Br. J. Cancer 104(4), 700–706 (2011).
  Medline CASGoogle Scholar
• 311 Yamato I, Sho M, Shimada K et al. PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and angiogenesis. Cancer Res. 72(18), 4829–4839 (2012).
  Medline CASGoogle Scholar
• 312 Bjornstad LG, Meza TJ, Otterlei M, Olafsrud SM, Meza-Zepeda LA, Falnes PO. Human ALKBH4 interacts with proteins associated with transcription. PLoS ONE 7(11), e49045 (2012).
  MedlineGoogle Scholar
• 313 Fu Y, He C. Nucleic acid modifications with epigenetic significance. Curr. Opin. Chem. Biol. 16(5–6), 516–524 (2012).
  Medline CASGoogle Scholar
• 314 Jia G, Fu Y, He C. Reversible RNA adenosine methylation in biological regulation. Trends Genet. 29(2), 108–115 (2013).
  Medline CASGoogle Scholar
• 315 Jia G, Fu Y, Zhao X et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat. Chem. Biol. 7(12), 885–887 (2011).▪▪ This series of papers establishes the 2-OG oxygenase FTO as risk factor of metabolic diseases and links them to N6-methyladenosine demethylation.
  Medline CASGoogle Scholar
• 316 Frayling TM, Timpson NJ, Weedon MN et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316(5826), 889–894 (2007).▪▪ This series of papers establishes the 2-OG oxygenase FTO as risk factor of metabolic diseases and links them to N6-methyladenosine demethylation.
  Medline CASGoogle Scholar
• 317 Gao X, Shin YH, Li M, Wang F, Tong Q, Zhang P. The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice. PLoS ONE 5(11), e14005 (2010).
  MedlineGoogle Scholar
• 318 Do R, Bailey SD, Desbiens K et al. Genetic variants of FTO influence adiposity, insulin sensitivity, leptin levels, and resting metabolic rate in the Quebec Family Study. Diabetes 57(4), 1147–1150 (2008).
  Medline CASGoogle Scholar
• 319 Jacobsson JA, Klovins J, Kapa I et al. Novel genetic variant in FTO influences insulin levels and insulin resistance in severely obese children and adolescents. Int. J. Obes. (Lond.) 32(11), 1730–1735 (2008).
  CASGoogle Scholar
• 320 Keller L, Xu W, Wang Hx, Winblad B, Fratiglioni L, Graff C. The obesity related gene, FTO, interacts with APOE, and is associated with Alzheimer's disease risk: a prospective cohort study. J. Alzheimers Dis. 23(3), 461–469 (2011).
  Medline CASGoogle Scholar
• 321 Lappalainen T, Kolehmainen M, Schwab US et al. Association of the FTO gene variant (rs9939609) with cardiovascular disease in men with abnormal glucose metabolism–the Finnish Diabetes Prevention Study. Nutr Metab Cardiovasc Dis 21(9), 691–698 (2011).
  Medline CASGoogle Scholar
• 322 Hubacek JA, Viklicky O, Dlouha D et al. The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population. Nephrol. Dial. Transplant 27(3), 1030–1035 (2012).
  Medline CASGoogle Scholar
• 323 Kaklamani V, Yi N, Sadim M et al. The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med. Genet. 12, 52 (2011).
  Medline CASGoogle Scholar
• 324 Tarabra E, Actis GC, Fadda M et al. The obesity gene and colorectal cancer risk: a population study in Northern Italy. Eur. J. Intern. Med. 23(1), 65–69 (2012).
  Medline CASGoogle Scholar
• 325 Boissel S, Reish O, Proulx K et al. Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. Am. J. Hum. Genet. 85(1), 106–111 (2009).
  Medline CASGoogle Scholar
• 326 Shimada K, Nakamura M, Anai S et al. A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression. Cancer Res. 69(7), 3157–3164 (2009).
  Medline CASGoogle Scholar
• 327 Lorsbach RB, Moore J, Mathew S, Raimondi SC, Mukatira ST, Downing JR. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 17(3), 637–641 (2003).▪▪ These papers collectively identify the 5-methylcytosine hydroxylases TET1-3 of critical importance in reversal of DNA methylation.
  Medline CASGoogle Scholar
• 328 Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, Hayashi Y. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res. 62(14), 4075–4080 (2002).▪▪ These papers collectively identify the 5-methylcytosine hydroxylases TET1-3 of critical importance in reversal of DNA methylation.
  Medline CASGoogle Scholar
• 329 Pastor Wa, Aravind L, Rao A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol. 14(6), 341–356 (2013).
  MedlineGoogle Scholar
• 330 Abdel-Wahab O, Mullally A, Hedvat C et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 114(1), 144–147 (2009).
  Medline CASGoogle Scholar
• 331 Comuzzie Ag, Cole Sa, Laston Sl et al. Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population. PLoS ONE 7(12), e51954 (2012).
  MedlineGoogle Scholar
• 332 Cao XJ, Arnaudo AM, Garcia BA. Large-scale global identification of protein lysine methylation in vivo. Epigenetics 8(5), 477–485 (2013).
  Medline CASGoogle Scholar
• 333 Chowdhury R, Yeoh KK, Tian YM et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12(5), 463–469 (2011).
  Medline CASGoogle Scholar
• 334 Watson JA, Watson CJ, Mccann A, Baugh J. Epigenetics, the epicenter of the hypoxic response. Epigenetics 5(4), 293–296 (2010).
  Medline CASGoogle Scholar
• 335 Edwards AM, Isserlin R, Bader GD, Frye SV, Willson TM, Yu FH. Too many roads not taken. Nature 470(7333), 163–165 (2011).
  Medline CASGoogle Scholar